Assistant Researcher, Clinical Laboratory Geneticist


Dr Florentia Fostira (F) is a Research C’ in the Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety at NCSR “Demokritos” since March 2020. She has been an Adjunct Researcher holding a Fellowship from SNF Foundation since July 2017. She has received the ‘’Unesco-L’oreal’’ Award for Women in Science for her scientific contribution, in 2014. She holds a Bachelor in Science degree in Molecular Biology from King’s College London, a Master’s in Science degree in Molecular Medicine from Imperial College London, UK and a PhD in Cancer Genetics from Molecular Biology and Genetics Department of University of Thrace. During her post-doctoral research in 2013, she worked in Professor Mary-Claire King’s laboratory at the University of Washington, USA where she was trained in next-generation sequencing technologies. She is a European Board-certified Clinical Laboratory Geneticist since 2017. Her main research interest focuses on hereditary cancer syndromes and the underlying genetic predisposition, which is implemented through the identification of predisposing genetic variants, which can be targeted therapeutically. She has more than 90 publications in peer-reviewed journals and her h-index is 31. She has supervised more than 10 student theses and she has given more than 200 oral presentations in National and International Conferences, following invination.

Selected Publications

Selected Grants

Hereditary Cancer predisposition, DNA homologous recombination mechanisms study

2018-2021 | ASTRAZENECA


Molecular Genetics Analysis in breast cancer

2018-2021 | ASTRAZENECA


Investigation of hereditary predisposition in polyposis and colorectal cancer



DEcision Support system for Tumor RadIogeNomics of the ovarY

2018-2022 | GSRT

Worldwide, high grade ovarian epithelial cancer (HGOC) remains the most fatal gynecological cancer. In patients with HGOC, the presence of intratumoral genetic heterogeneity is considered an important adverse prognostic factor associated with poor response to treatment and, therefore, poor survival ...


Hellenic Precision Medicine Network on Cancer

2018-2021 | SIEMENS - GSRT

ATTICA MEDICAL PRECISION UNIT 2 Coordinator: National Research Center for Natural Sciences "Demokritos" Partners: National Research Foundation, Alexander Fleming Biomedical Research Center Within the framework of the National Precision Medicine Network, the Precision Medicine Unit at NCSR "...

INRASTES - Official Web Site
Skip to content